tirzepatide fda decision Wins Approval for Weight Loss Is Tirzepatide FDA Approved?

Fatigue during this window is a signal that adaptation is happening, not a sign something is wrong

Rotate injection sites to minimize site reactions and improve absorption consistency

Liver & NAFLD/NASH: Ongoing research explores impacts on liver fat, transaminases, and nonalcoholic fatty-liver diseaserelated endpoints

Drug discontinuation occurred in 26% of the participants, slightly higher for semaglutide (12.6%) than placebo (11.3%) mostly driven by GI effects

Create a bedtime routine, limit screen time before bed, and aim for 7-9 hours of uninterrupted rest each night

Resistance to Loss: Your body actively resists further weight loss, setting a challenging new defense point that requires a new strategy completely